Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...

The translation of preclinical studies of a novel therapeutic into successful phase 2 and 3 trials is a process that frequently fails, despite high-quality basic research and well-conducted clinical ...